Literature DB >> 23449935

IL-6 is not essential for exercise-induced increases in glucose uptake.

Hayley M O'Neill1, Rengasamy Palanivel, David C Wright, Tara MacDonald, James S Lally, Jonathan D Schertzer, Gregory R Steinberg.   

Abstract

Interleukin-6 (IL-6) increases glucose uptake in resting skeletal muscle. IL-6 is released from skeletal muscle during exercise; however; it is not known whether this IL-6 response is important for exercise-induced increases in skeletal muscle glucose uptake. We report that IL-6 knockout (KO) mice, 4 mo of age, have similar body weight to wild-type (WT), and, under resting conditions, oxygen consumption, food intake, substrate utilization, glucose tolerance, and insulin sensitivity are not different. Maximal exercise capacity is also similar to WT. We investigated substrate utilization and glucose clearance in vivo during steady-state treadmill running at 70% of maximal running speed and found that WT and IL-6 KO mice had similar rates of substrate utilization, muscle glucose clearance, and phosphorylation of AMP-activated protein kinase T172. These data provide evidence that IL-6 does not play a major role in regulating substrate utilization or skeletal muscle glucose uptake during steady-state endurance exercise.

Entities:  

Keywords:  AMP-activated protein kinase; exercise; fatty acid oxidation; glucose uptake; insulin sensitivity; interleukin-6

Mesh:

Substances:

Year:  2013        PMID: 23449935     DOI: 10.1152/japplphysiol.00946.2012

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  11 in total

Review 1.  Exercise-stimulated glucose uptake - regulation and implications for glycaemic control.

Authors:  Lykke Sylow; Maximilian Kleinert; Erik A Richter; Thomas E Jensen
Journal:  Nat Rev Endocrinol       Date:  2016-10-14       Impact factor: 43.330

2.  IL-6 and epinephrine have divergent fiber type effects on intramuscular lipolysis.

Authors:  Tara L Macdonald; Zhongxiao Wan; Scott Frendo-Cumbo; David J Dyck; David C Wright
Journal:  J Appl Physiol (1985)       Date:  2013-09-19

3.  Interleukin-13 drives metabolic conditioning of muscle to endurance exercise.

Authors:  Nelson H Knudsen; Kristopher J Stanya; Alexander L Hyde; Mayer M Chalom; Ryan K Alexander; Yae-Huei Liou; Kyle A Starost; Matthew R Gangl; David Jacobi; Sihao Liu; Danesh H Sopariwala; Diogo Fonseca-Pereira; Jun Li; Frank B Hu; Wendy S Garrett; Vihang A Narkar; Eric A Ortlund; Jonathan H Kim; Chad M Paton; Jamie A Cooper; Chih-Hao Lee
Journal:  Science       Date:  2020-04-30       Impact factor: 47.728

Review 4.  Interleukin 6 as an energy allocator in muscle tissue.

Authors:  Timothy M Kistner; Bente K Pedersen; Daniel E Lieberman
Journal:  Nat Metab       Date:  2022-02-24

5.  Role of gp130 in basal and exercise-trained skeletal muscle mitochondrial quality control.

Authors:  Dennis K Fix; Justin P Hardee; Song Gao; Brandon N VanderVeen; Kandy T Velázquez; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2018-02-01

Review 6.  "Weighing" the effects of exercise and intrinsic aerobic capacity: are there beneficial effects independent of changes in weight?

Authors:  John P Thyfault; David C Wright
Journal:  Appl Physiol Nutr Metab       Date:  2016-05-06       Impact factor: 2.665

7.  Voluntary physical activity prevents insulin resistance in a tissue specific manner.

Authors:  Jessica L Sarvas; Jeffrey S Otis; Neelam Khaper; Simon J Lees
Journal:  Physiol Rep       Date:  2015-02-22

8.  The contribution of IL-6 to beta 3 adrenergic receptor mediated adipose tissue remodeling.

Authors:  Samyra L Buzelle; Rebecca E K MacPherson; Willem T Peppler; Laura Castellani; David C Wright
Journal:  Physiol Rep       Date:  2015-02-22

9.  Lack of Skeletal Muscle IL-6 Affects Pyruvate Dehydrogenase Activity at Rest and during Prolonged Exercise.

Authors:  Anders Gudiksen; Camilla Lindgren Schwartz; Lærke Bertholdt; Ella Joensen; Jakob G Knudsen; Henriette Pilegaard
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

10.  Exercise Protects Against Olanzapine-Induced Hyperglycemia in Male C57BL/6J Mice.

Authors:  Laura N Castellani; Willem T Peppler; Paula M Miotto; Natasha Bush; David C Wright
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.